Cancer Clinical Trial
— PROGNOSIS-RCTOfficial title:
Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients With Solid Cancers (PROGNOSIS-RCT)
A Randomized Clinical Trial examining the effects of Comprehensive Geriatric Assessment as an add on to oncologic treatment. Participants included are cancer patients found eligible for oncologic treatment, age 70 or more, and screened frail with the Geriatric 8 screening tool.
Status | Recruiting |
Enrollment | 322 |
Est. completion date | June 1, 2024 |
Est. primary completion date | November 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility | Inclusion Criteria: - Age = 70 years - Living in the region of Southern Denmark - Newly diagnosed solid tumours assessed eligible for antineoplastic treatment - Vulnerable or frail (G8 = 14) Exclusion Criteria: - Inability to speak or understand Danish - Inability to give informed consent - Already consulting geriatric outpatient clinic - Already receiving active treatment for other coexisting solid tumours, haematologic cancers, or non-melanoma skin cancer or has received oncologic treatment the past year |
Country | Name | City | State |
---|---|---|---|
Denmark | Odense University Hospital | Odense | Southern Denmark |
Lead Sponsor | Collaborator |
---|---|
Odense University Hospital | Academy of Geriatric Cancer, Danish Cancer Society, Odense Patient Data Explorative Network, Region of Southern Denmark, University of Southern Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | physical function for patients receiving palliative oncologic treatment | measured by 30 seconds Chair Stand Test, number of repetitions in a 30 seconds time period. | 3 months | |
Primary | unplanned hospital admissions for patients receiving adjuvant oncologic treatment | number of unplanned hospitalisations including admissions to Oncologic Department, Emergency Department and Medical Departments. Data will be retrieved trough review of electronic medical records. | 6 months | |
Secondary | Physical functional for patients receiving curative oncologic treatment | measured by 30 seconds Chair Stand Test, number of repetitions in a 30 seconds time period. | 3 months | |
Secondary | Physical functional for patients receiving curative oncologic treatment | measured by 30 seconds Chair Stand Test, number of repetitions in a 30 seconds time period. | 6 months | |
Secondary | Physical functional for patients receiving palliative oncologic treatment | measured by 30 seconds Chair Stand Test, number of repetitions in a 30 seconds time period. | 6 months | |
Secondary | number of unplanned hospital admissions for patients receiving palliative oncologic treatment | Number of unplanned hospitalisations including admissions to Oncologic Department, Emergency Department and Medical Departments. Data will be retrieved trough review of electronic medical records. | 6 months | |
Secondary | Health-related Quality of life | Measured by EORTC-QLQ-C30 | 12 months | |
Secondary | Health-related Quality of life | Measured by EORTC-QLQ-ELD14 | 12 months follow-up | |
Secondary | Elderly Functional Index Score (ELFI-score) | Self reported functioning score. It is a composite score derived from the three scales "physical functioning", "Role functioning" and Social Functioning", from the quality of life questionnaire EORTC-QLQ-C30 and the scale "Mobility" from the quality of life questionnaire EORTC-QLQ-ELD-14. The range is (12-48), with a higher score being a better outcome. | 6 months | |
Secondary | Number of patients who experience oncologic treatment toxicity | Treatment toxicity grade 3+ evaluated with Common Terminology Criteria for Adverse Events | 6 months | |
Secondary | Number of patients with adherence to initial oncologic treatment plan | Registration of dose reductions, discontinuations and delays of intended cancer treatment. | 6 months | |
Secondary | Degree of Polypharmacy (PP) | Degree of polypharmacy. Polypharmacy is defined as daily use of more than 5 prescription drugs. | 3 months | |
Secondary | Number of potential Inappropriate Medications (PIM) | Using the Screening Tool for Older Persons Prescriptions (STOPP) criteria. Number of PIM will be registered for each patient | 3 months | |
Secondary | Number of Potential Drug Interactions (PDI) | Using Stockley's Drug Interaction Database. Number of PDI will be registered for each patient | 3 months | |
Secondary | Overall survival | Measured from Geriatric 8 screening to time of death | 12 months | |
Secondary | Cancer specific survival | Measured from Geriatric 8 screening to time of death in patients with residual cancer | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|